These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3102725)

  • 1. The paradox of gold compounds: activators or inhibitors?
    Parente JE; Wong K; Davis P
    J Rheumatol; 1986 Oct; 13(5):846-8. PubMed ID: 3102725
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral gold in rheumatoid arthritis.
    Drug Ther Bull; 1988 Sep; 26(18):69-72. PubMed ID: 3139386
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
    Iqbal MS; Saeed M; Taqi SG
    Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin-induced vasomotor reaction.
    Proudman SM; Cleland LG
    Arthritis Rheum; 1992 Dec; 35(12):1452-4. PubMed ID: 1472122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog.
    Bloom JC; Thiem PA; Halper LK; Saunders LZ; Morgan DG
    J Rheumatol; 1988 Mar; 15(3):409-17. PubMed ID: 3132555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of auranofin: overview and update.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1986; 63():19-28. PubMed ID: 3110942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 12. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
    Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H
    Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin.
    Hirohata S; Nakanishi K; Yanagida T; Kawai M; Kikuchi H; Isshi K
    Clin Immunol; 1999 May; 91(2):226-33. PubMed ID: 10227815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
    Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983.
    Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.